Abstract
BackgroundTocilizumab (TCZ) showed highly efficacious in rheumatoid arthritis (RA) in the clinical trials, although there is little evidence in daily clinical practice. We have already reported the effects of TCZ...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have